A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics

被引:0
|
作者
Huisman, M. V. [1 ]
Diener, H. -C. [2 ]
Dubner, S. J. [3 ]
Halperin, J. L. [4 ]
Rothman, K. J. [5 ]
Ma, C. -S. [6 ]
Lu, S. [7 ]
Paquette, M. [8 ]
Teutsch, C. [9 ]
Franca, L. R. [9 ]
Zint, K. [9 ]
Lip, G. Y. H. [10 ]
机构
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Univ Hosp Essen Ruhr, Essen, Germany
[3] Clin & Matern Suizo Argentina, Buenos Aires, DF, Argentina
[4] Mt Sinai Sch Med, New York, NY USA
[5] RTI Hlth Solut, Durham, NC USA
[6] Beijing Anzhen Hosp, Beijing, Peoples R China
[7] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
[8] Boehringer Ingelheim Ltd, Burlington, ON, Canada
[9] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[10] Birmingham City Hosp, Birmingham, W Midlands, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P3862
引用
收藏
页码:825 / 825
页数:1
相关论文
共 50 条
  • [1] A PROSPECTIVE GLOBAL REGISTRY ON ORAL ANTITHROMBOTIC TREATMENT IN PATIENTS WITH ATRIAL FIBRILLATION: GLORIA-AF PHASE III BASELINE CHARACTERISTICS
    Huisman, M.
    Diener, H.
    Dubner, S.
    Halperin, J.
    Rothman, K.
    Ma, C.
    Lu, S.
    Paquette, M.
    Teutsch, C.
    Franca, L.
    Zint, K.
    Lip, G.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0E) : E113 - E113
  • [2] Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program
    Beier, Lea
    Lu, Shihai
    Franca, Lionel Riou
    Marler, Sabrina
    Lip, Gregory Y. H.
    Huisman, Menno, V
    Teutsch, Christine
    Halperin, Jonathan L.
    Zint, Kristina
    Diener, Hans-Christoph
    Baker, Laurie
    Ma, Chang-Sheng
    Paquette, Miney
    Bartels, Dorothee B.
    Dubner, Sergio J.
    Lyrer, Philippe
    Senges, Jochen
    Rothman, Kenneth J.
    PLOS ONE, 2022, 17 (10):
  • [3] Patterns of pharmacological treatment in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF Registry Phase III
    Corica, Bernadette
    Romiti, Giulio Francesco
    Boriani, Giuseppe
    Olshansky, Brian
    Chao, Tze-Fan
    Huisman, Menno V.
    Proietti, Marco
    Lip, Gregory Y. H.
    GLORIA AF Investigators
    BMC MEDICINE, 2025, 23 (01):
  • [4] Antithrombotic Therapy in Patients With Atrial Fibrillation and Prior Stroke in GLORIA-AF Phase II (Global Registry on Long-term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation, Phase II).
    Diener, Hans-Christoph
    Huisman, Menno, V
    Halperin, Jonathan L.
    Dubner, Sergio J.
    Ma, Chang S.
    Rothman, Kenneth J.
    Zint, Kristina
    Elsaesser, Amelie
    Paquette, Miney
    Teutsch, Christine
    Bartels, Dorothee
    STROKE, 2016, 47
  • [5] Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF
    Koziel, Monika
    Teutsch, Christine
    Halperin, Jonathan L.
    Rothman, Kenneth J.
    Diener, Hans-Christoph
    Ma, Chang-Sheng
    Marler, Sabrina
    Lu, Shihai
    Gurusamy, Venkatesh K.
    Huisman, Menno, V
    Lip, Gregory Y. H.
    PLOS ONE, 2021, 16 (04):
  • [6] Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II
    Huisman, Menno V.
    Rothman, Kenneth J.
    Paquette, Miney
    Teutsch, Christine
    Diener, Hans Christoph
    Dubner, Sergio J.
    Halperin, Jonathan L.
    Ma, Changsheng
    Zint, Kristina
    Elsaesser, Amelie
    Bartels, Dorothee B.
    Lip, Gregory Y. H.
    AMERICAN JOURNAL OF MEDICINE, 2015, 128 (12): : 1306 - +
  • [7] Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry
    Bayer, Valentina
    Kotalczyk, Agnieszka
    Kea, Bory
    Teutsch, Christine
    Larsen, Peter
    Button, Dana
    Huisman, Menno, V
    Lip, Gregory Y. H.
    Olshansky, Brian
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (06):
  • [8] Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry
    Mazurek, Michal
    Huisman, Menno V.
    Rothman, Kenneth J.
    Paquette, Miney
    Teutsch, Christine
    Diener, Hans-Christoph
    Dubner, Sergio J.
    Halperin, Jonathan L.
    Ma, Chang Sheng
    Zint, Kristina
    Elsaesser, Amelie
    Lu, Shihai
    Lip, Gregory Y. H.
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (12) : 2376 - 2388
  • [9] Use of antithrombotic therapy in patients with atrial fibrillation and prior stroke: insights from the global GLORIA-AF registry
    Lip, G. Y. H.
    Halperin, J. L.
    Diener, H. C.
    Dubner, S. J.
    Ma, C. S.
    Rothman, K. J.
    Zint, K.
    Elsaesser, A.
    Paquette, M.
    Huisman, M. V.
    EUROPEAN HEART JOURNAL, 2015, 36 : 243 - 243
  • [10] Patterns of Newly Detected Atrial Fibrillation and Antithrombotic Treatment in GLORIA-AF Phase II
    Halperin, Jonathan L.
    Huisman, Menno V.
    Diener, Hans-Christoph
    Dubner, Sergio J.
    Ma, Changsheng
    Rothman, Kenneth J.
    Schoof, Nils
    Elsaesser, Amelie
    Paquette, Miney
    Bartels, Dorothee B.
    Teutsch, Christine
    Lip, Gregory H.
    CIRCULATION, 2015, 132